secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0001193125-23-241886
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen to acquire Metenova for cash and equity; adds magnetic mixing technology
--------------------------------------------------------------------------------

- Metenova projected FY2023 revenue $24-25M; ~50 employees; magnetic mixers for bioprocess.
- Expected close Q4 2023; funded with ~$604M cash on hand (cash + equity consideration).
- Metenova expected to contribute $5M revenue in Q4 2023, $25-27M in 2024, 20-25% growth in 2025.
- Deal projected accretive to adjusted gross/operating margins in 2024 and adjusted EPS in 2025.
- Adds single-use MixOne platform; complements Repligen's fluid management and FlexBiosys bag business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312523241886/0001193125-23-241886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312523241886/d561194d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-241886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer